FDA.reportPublic FDA data

Relexxii 27 MG 24 HR Extended Release Oral Tablet

RxCUI
2668499
RxNorm name
Relexxii 27 MG 24 HR Extended Release Oral Tablet
Display name
Relexxii 27 MG 24 HR Extended Release Oral Tablet
Full name
Relexxii 27 MG 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RELEXXIIMETHYLPHENIDATE HYDROCHLORIDEVertical Pharmaceuticals, LLC22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d2025-09-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2668499

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
22d5fa47-b5b9-4fd9-980c-4eb88e95ae5dRelexxii 27 MG 24 HR Extended Release Oral TabletSY18These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 200020250926
22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet [Relexxii]SBD18These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 200020250926
22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d24 HR Relexxii 27 MG Extended Release Oral TabletSY18These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 200020250926
22d5fa47-b5b9-4fd9-980c-4eb88e95ae5dRELEXXII 27 MG 24HR Extended Release Oral TabletPSN18These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 200020250926